dc.contributor.author | Pasternak, Björn | |
dc.contributor.author | Wintzell, Viktor | |
dc.contributor.author | Mellbye, Mads | |
dc.contributor.author | Eliasson, Björn | |
dc.contributor.author | Svensson, Ann-Marie | |
dc.contributor.author | Franzén, Stefan | |
dc.contributor.author | Gudbjörnsdóttir, Soffia | |
dc.contributor.author | Hveem, Kristian | |
dc.contributor.author | Jonasson, Christian | |
dc.contributor.author | Svanström, Henrik | |
dc.contributor.author | Ueda, Peter | |
dc.date.accessioned | 2023-05-08T10:31:45Z | |
dc.date.available | 2023-05-08T10:31:45Z | |
dc.date.created | 2020-06-09T14:51:47Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | BMJ (Clinical Research Edition). 2020, 369 . | |
dc.identifier.issn | 0959-8138 | |
dc.identifier.uri | https://hdl.handle.net/11250/3066913 | |
dc.language.iso | eng | |
dc.title | Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 9 | |
dc.source.volume | 369 | |
dc.source.journal | BMJ (Clinical Research Edition) | |
dc.identifier.doi | 10.1136/bmj.m1186 | |
dc.identifier.cristin | 1814595 | |
dc.relation.project | Stiftelsen Kristian Gerhard Jebsen: SKGJ-MED-015 | |
dc.relation.project | Norges forskningsråd: 248817 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |